Cost‐effectiveness of Endoscopic Surveillance for Gastric Intestinal Metaplasia
- 7 May 2010
- journal article
- Published by Wiley in Helicobacter
- Vol. 15 (3) , 221-226
- https://doi.org/10.1111/j.1523-5378.2010.00752.x
Abstract
Patients with intestinal metaplasia (IM) are at increased risk for gastric cancer. Endoscopic surveillance has been shown to anticipate cancer diagnosis in an earlier stage. Cost-effectiveness of endoscopic surveillance in IM patients is unknown. To assess the efficacy and cost-effectiveness of an yearly endoscopic surveillance in patients with IMKeywords
This publication has 20 references indexed in Scilit:
- Helicobacter pylori eradication for gastric cancer preventionThe Esophagus, 2007
- Relationship between b -catenin expression and epithelial cell proliferation in gastric mucosa with intestinal metaplasiaWorld Journal of Gastroenterology, 2005
- Intestinal metaplasia and gastric carcinogenesisAlimentary Pharmacology & Therapeutics, 2002
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancerInternational Journal of Cancer, 1999
- Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyPublished by Elsevier ,1997
- Gastric CarcinomaNew England Journal of Medicine, 1995
- Intestinal metaplasia types and the risk of gastric cancer: A cohort study in SloveniaInternational Journal of Cancer, 1994
- Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum.Gut, 1992
- Sulphomucins and precancerous lesions of the human stomachHistopathology, 1980